Displaying drugs 2851 - 2875 of 3092 in total
L-778123
Experimental
Madecassoside
Experimental
Tolrestat
Tolrestat (INN) (AY-27773) is an aldose reductase inhibitor which was approved for the control of certain diabetic complications. While it was approved for marketed in several countries, it failed a Phase III trial in the U.S. due to toxicity and never received FDA approval. It was sold under the tradename...
Withdrawn
3-Isopropylmalic Acid
Experimental
Adenylosuccinic acid
Experimental
BMS-181156
Experimental
Inhibitor Idd 384
Experimental
2,6-anhydro-3-deoxy-3-fluoronononic acid
Experimental
S-3APG
S-3APG (S-3-[3-amino-phthalimido]-glutarimide) is a derivative of thalidomide with dual activity against B-cell neoplasias.
Investigational
N-acetyl-beta-D-galactosamine 6-sulfate
Experimental
Prinomastat
Prinomastat is a synthetic hydroxamic acid derivative with potential antineoplastic activity. Prinomastat inhibits matrix metalloproteinases (MMPs) (specifically, MMP-2, 9, 13, and 14), thereby inducing extracellular matrix degradation, and inhibiting angiogenesis, tumor growth and invasion, and metastasis. As a lipophilic agent, prinomastat crosses the blood-brain barrier.
Investigational
Pinazepam
Experimental
PG-701
Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Valrocemide
Investigational
(S)-methoprene
Vet approved
Acetylcysteine amide
Experimental
Displaying drugs 2851 - 2875 of 3092 in total